Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?

被引:0
作者
Jasmina Mallet
Nicolas Ramoz
Yann Le Strat
Philip Gorwood
Caroline Dubertret
机构
[1] University Hospital Louis-Mourier,Department of Psychiatry
[2] Assistance Publique-Hôpitaux de Paris (AP-HP),Faculty of Medicine
[3] University Paris 7 Denis Diderot,INSERM U894
[4] Center of Psychiatry and Neuroscience,CMME
[5] University Paris 5 René Descartes,undefined
[6] PRES Sorbonne Paris cité,undefined
[7] Sainte-Anne Hospital,undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2017年 / 267卷
关键词
Schizophrenia; Neurological soft signs; Cannabis; Cognition; Neurodevelopment;
D O I
暂无
中图分类号
学科分类号
摘要
Cannabis use is associated with an increased risk of schizophrenia, and is considered to impact late neurodevelopment. Neurological soft signs (NSS) associated with schizophrenia are considered as markers of early neurodevelopmental impairment. Our study examines the association between heavy cannabis use before the onset of psychosis and clinical, neuropsychological and neurological symptoms, including NSS. In a cross-sectional study, we consecutively included 61 patients with schizophrenia (34 reporting heavy cannabis use before the onset of psychosis and 27 not reporting such use), in the setting of a University Hospital and a Medical Center. Symptoms assessment and substance use disorder were evaluated with the Diagnostic Interview for Genetic Studies. NSS were assessed with the Neurological Evaluation Scale. Psychopathology was assessed with the Positive and Negative Symptom Scale. All patients underwent a battery of neurocognitive tests evaluating attention, memory and executive functions domains. Patients with heavy cannabis use before the onset of psychosis showed significantly less NSS (p < 0.05), less negative symptoms (p < 10−3) and a better cognitive functioning in different domains [median reaction time (p = 0.03), episodic memory (p = 0.04), visuoconstructive praxs (p = 0.03) than their non-heavy user counterparts]. Confounding effects of alcohol and tobacco were taken into account. Age and gender were not statistically different between the two groups (p = 0.70 and p = 0.16, respectively). Our study supports the clinical, neuropsychological and neurological specificity associated with the heavy use of cannabis before the onset of schizophrenia. Patients with heavy cannabis use before the onset of schizophrenia may exhibit later neurodevelopmental impairment than those who do not report such use. Schizophrenia associated with heavy cannabis use could represent a specific phenotype.
引用
收藏
页码:629 / 638
页数:9
相关论文
共 160 条
[11]  
Abelson JM(2007)Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet Lond Engl 370 319-328
[12]  
Kessler RC(2010)Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia Psychiatry Res 181 51-56
[13]  
Dervaux A(2015)Altered cortical maturation in adolescent cannabis users with and without schizophrenia Schizophr Res 162 143-152
[14]  
Laqueille X(2009)Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use Schizophr Res 107 158-164
[15]  
Bourdel MC(2014)Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders Epilepsia 55 791-802
[16]  
Bahorik AL(2016)Could cannabidiol be used as an alternative to antipsychotics? J Psychiatr Res 80 14-21
[17]  
Newhill CE(2009)The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning Psychol Med 39 1607-1616
[18]  
Queen CC(2004)The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 29 1558-1572
[19]  
Eack SM(2012)The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample Schizophr Bull 38 316-330
[20]  
Bersani G(2013)Cannabis use and cognitive functions in at-risk mental state and first episode psychosis Psychopharmacology (Berl) 230 299-308